Junshi Biosciences and Coherus Announce Positive Results from Phase 3 Esophageal Cancer Study of Toripalimab Published in Cancer Cell
– Toripalimab plus chemotherapy demonstrates improvement in co-primary endpoints of PFS and OS in patients
POSTS IN CATEGORY
– Toripalimab plus chemotherapy demonstrates improvement in co-primary endpoints of PFS and OS in patients
OKX becomes Manchester City’s Official Cryptocurrency Partner Manchester City and OKX have today announced a
New York/Berlin/Kyiv, March 04, 2022 (GLOBE NEWSWIRE) — The Open Society Foundations today are pledging
Company expansion and investments fuel 40% growth in global customer base and 24% growth in network
VICTOR, N.Y., March 03, 2022 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ and STZ.B),
Nyxoah to Release Full Year 2021 Financial Results on March 24 and Host Conference Call
BIRMINGHAM, Ala., March 03, 2022 (GLOBE NEWSWIRE) — Harbert Management Corporation (“HMC”) announces that Lee
The fully customizable 75% layout mechanical keyboard is packed with premium features and unlimited possibilities
Sultan Sharif Ali Islamic University, UNISSA, held the Isra ‘Mi’raj Celebration. The ceremony took place
Copyright 2024 © bruneitribune.com All rights Reserved.